3116
M.A. Pujana et al. / Polymer 53 (2012) 3107e3116
[2] Chandy T, Sharma CP. Artif Cells Artif Organs 1990;18(1):1e24.
45
40
35
30
25
[3] Nishimura K, Nishimura S, Nishi N, Numata F, Tone Y, Tokura S, et al. Vaccine
1985;3(5):379e84.
[4] Qi L, Xu Z, Chen M. Eur J Cancer 2007;43(1):184e9.
[5] Van der Lubben IM, Verhoef JC, Borchard G, Junginger HE. Adv Drug Deliv Rev
2001;52(2):139e44.
[6] Zaharoff DA, Rogers CJ, Hance KW, Schlom J, Greiner JW. Vaccine 2007;25(11):
2085e94.
[7] Rinaudo M. Prog Polym Sci 2006;31(7):603e32.
[8] Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. Int J Pharm 1992;78(1e2):
43e8.
[9] Illum L, Farraj NF, Davis SS. Pharm Res 1994;11(8):1186e9.
[10] Alonso MJ, Salve P, Remunan-Lopez C, Vila-Jato JL. Eur Patent; 1998. 0860-
166-A1.
[11] Alonso MJ, Sánchez AJ. Pharm Pharmacol 2003;55(11):1451e63.
[12] Nishimura SI, Kohgo O, Kurita K, Kuzuhara H. Macromolecules 1991;24(17):
4745e8.
[13] Fischer D, Bieber T, Li Y, Elsaesser HP, Kissel T. Pharm Res 1999;16(8):1273e9.
[14] Muzzarelli RAA, Tanfani F, Emanuelli M. Carbohydr Res 1984;126(2):225e31.
[15] Saito H, Wu X, Harris J, Hoffman A. Macromol Rapid Commun 1997;18(7):
547e50.
[16] Enescu D, Olteanu CE. Chem Eng Commun 2008;195(10):1269e91.
[17] Berger J, Reist M, Mayer JM, Felt O, Peppas NA, Gurny R. Eur J Pharm Biopharm
2004;57(1):19e34.
10
20
30
40
50
60
70
80
[18] Kristl J, Smid-Korbar J, Strue E, Schara M, Rupprecht H. Int J Pharm 1993;
99(1):13e9.
Cross-linker (mol. %)
[19] Park HJ, Jung ST, Song JJ, Kang SG, Vergano PJ, Testin RF. Chitin Chitosan Res
1999;5(1):19e26.
[20] Wang LY, Ma GH, Su ZG. J Control Rel 2005;106(1e2):62e75.
[21] Agnihotri SA, Aminabhavi TM. Drug Dev Ind Pharm 2007;33(11):1254e62.
[22] Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ. J Appl Polym Sci 1997;
63(1):25e132.
Fig. 11. Zeta potential for (,) tartaric acidechitosan and (C) PEGechitosan nanogels
at pH ¼ 4.0 as function of crosslinker content.
4. Conclusions
[23] López-León T, Carvalho ELS, Seijo B, Ortega-Vinuesa JL, Bastos-González D.
J Colloid Interface Sci 2005;283(2):344e51.
Chitosan was successfully crosslinked by amidation reaction
using biocompatible dicarboxylic acids (PEGdiacid and tartaric
acid) by w/o microemulsion to form ultrafine nanoparticles
(10e15 nm TEM). PEGdiacid showed to be more efficient for chi-
tosan crosslinking than tartaric acid. Water solubility of the
samples was improved in comparison with linear chitosan and
furthermore, in most of cases the new systems were stable at
physiological pH.
The synthesized nanogels showed a pH-responsive swelling
behaviour that corresponds to the pKa of the non-crosslinked
chitosan. The particle size of colloid dispersion varied from 250 to
450 nm by decreasing the pH from 8 to 4. The pKa values of
resulting nanoparticles estimated by Zeta potential measurements
were around 5.9e6.2. The swelling capacity and surface charge
clearly depends on the hydrophilic character and flexibility of the
crosslinker.
[24] Zhang H, Oh M, Allen C, Kumacheva E. Biomacromolecules 2004;5(6):2461e8.
[25] Khalid MN, Ho L, Agnely JL, Grossiord JL, Couarraze G. STP Pharm Sci 1999;
9(4):359e64.
[26] Yang ZK, Yuan Y. J Appl Polym Sci 2001;82(8):1838e43.
[27] Crescenzi V, Paradossi G, Desideri P, Dentini M, Cavalieri F, Amici E, et al.
Polym Gels Netw 1997;5(3):225e39.
[28] Mi FL, Tan YC, Liang HF, Sung HW. Biomaterials 2002;23(1):181e91.
[29] Beauchamp O, St Clair MB, Fennell TR, Clarke DO, Morgan KT. Crit Rev Toxicol
1992;22(3e4):143e74.
[30] Du J, Hsieh JL. Cellulose 2007;14(6):543e52.
[31] Kulkarni AR, Hukkeri VI, Sung HW, Liang HF. Macromol Biosci 2005;5(10):
925e8.
[32] Kiuchi H, Kai W, Inoue YJ. Appl Polym Sci 2008;107(6):3823e30.
[33] Bodnar M, Hartmann JF, Borbely J. Biomacromol 2006;7(11):3030e6.
[34] Bodnar M, Hartmann JF, Borbely J. Biomacromol 2005;6(5):2521e7.
[35] Chow PY, Gang LM. Adv Polym Sci 2005;175:257e98.
[36] Leong YS, Candau F. J Phys Chem 1982;86(13):2269e71.
[37] Liu G, Shao L, Gea F, Chena J. China Particuol 2007;5(6):384e90.
[38] Banerjee T, Mitra S, Singh AK, Sharma RK, Maitra A. Int J Pharm 2002;
243(1e2):93e105.
[39] Tallury P, Kar S, Bamrungsap S, Huang YF, Tand W, Santra S. Chem Commun
2009;17:2347e9.
[40] Maggi F, Ciccarelli S, Diociaiuti M, Casciardi S, Masci G. Biomacromol 2011;
12(10):3499e507.
The water solubility at physiological pH and the pH-responsive
swelling of the synthesized nanogels make them attractive candi-
dates as biocarriers for a large variety of biomedical applications.
[41] Schulz PC, Rodriguez MS, Del Blanco LF, Pistonesi M, Agullo E. Colloid Polym
Sci 1998;276(12):1159e65.
Acknowledgements
[42] Kasaai MR. Carbohydr Polym 2010;79(4):801e10.
[43] Rinaudo M, Milas M, Dung PL. Int J Biol Macromol 1993;15(5):281e5.
[44] Sánchez A, Sibaja M, Vega-Baudrit J, Madrigal S. Rev Iber Polim 2007;8(5):4.
[45] Olde Damink LHH, Dijkstra PJ, van Luyn MJA, van Wachem PB, Nieuwenhuis P,
Feijen J. Biomaterials 1996;17(8):765e73.
[46] Wu C, Zhou S, Wang W. Biopolymers 1995;35(3):385e92.
[47] Sorlier P, Rochas C, Morfin I, Viton C, Domard A. Biomacromol 2003;4(4):
1034e40.
Financial support for this work was provided by the Basque
Government and the University of the Basque Country (UPV/EHU),
for awarding a fellowship.
References
[48] Flory PJ, Rehner J. J Chem Phys 1943;11:521.
[49] Chan P, Kurisawa M, Chung JE, Yang YY. Biomaterials 2007;28(3):540e9.
[50] Schatz C, Pichot C, Delair T, Viton C, Domard A. Langmuir 2003;19(23):
9896e903.
[1] Kockisch S, Rees GD, Young SA, Tsibouklis J, Smart JD. J Pharm Sci 2003;92(8):
1614e23.